uniQure NV Share Price Today: Live Updates & Key Insights
uniQure NV share price today is $16.37, up 5.44%. The stock opened at $15.27 against the previous close of $15.26, with an intraday high of $17.7 and low of $15.27.
uniQure NV Share Price Chart
uniQure NV Share Price Performance
uniQure NV Institutional Holdings
uniQure NV Market Status
uniQure NV Fundamentals
Market Cap 1006.10 M
PB Ratio 5.0614
PE Ratio 0.0
Enterprise Value 447.58 M
Total Assets 824.91 M
Volume 5757928
uniQure NV Company Financials
About uniQure NV & investment objective
Company Information uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Organisation Biotechnology
Employees 221
Industry Biotechnology
CEO Mr. Matthew Craig Kapusta CPA
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
uniQure NV FAQs
What is the share price of uniQure NV today?
The current share price of uniQure NV is $16.37.
Can I buy uniQure NV shares in India?
Yes, Indian investors can buy uniQure NV shares by opening an international trading and demat account with Motilal Oswal.
How to buy uniQure NV shares in India?
You can easily invest in uniQure NV shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy uniQure NV shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of uniQure NV.
Can I buy fractional shares of uniQure NV?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of uniQure NV?
uniQure NV has a market cap of $1006.10 M.
In which sector does uniQure NV belong?
uniQure NV operates in the Biotechnology sector.
What documents are required to invest in uniQure NV stocks?
To invest, you typically need:
What is the PE and PB ratio of uniQure NV?
The PE ratio of uniQure NV is N/A and the PB ratio is 5.06.